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Abstract
Background: Amyotrophic Lateral Sclerosis is a devastating, untreatable motor neuron disease with unknown causes, but nutritional and lifestyle 
factors may play a role. To check this hypothesis, we conducted a multicentre cross-sectional study.
Material and methods: This study recruited 241 patients, 96 females, and 145 males; the mean age at onset – 59.9±11.8 years. According to El 
Escorial criteria, 74 patients were definite ALS, 77 – probable, 55 – possible, and 35 –suspected; 187 patients had spinal onset and 54 – bulbar. 
Patients were categorized into three groups, according to their ΔFS: slow (81), intermediate (80), and fast progressors (80).
Results: Current coffee consumers were 179 (74.3%), 34 (14.1%) were non-consumers, 22 (9.1%) – former consumers. The log-ΔFS was weakly 
correlated with the duration of coffee consumption (p=0.034), but not with the number of cup-years, or the intensity of coffee consumption 
(cups/day). Current tea consumers were 101 (41.9%), 6 (2.5%) were former-consumers, and 134 (55.6%) – non-consumers. The log-ΔFS was 
weakly correlated only with the consumption duration of black tea (p=0.028) but not with the number of cup-years. Current smokers were 44 
(18.3%), former smokers – 10 (4.1%), and non-smokers – 187 (77.6%). The age of ALS onset was lower in current smokers than non-smokers, 
and the ΔFS was slightly, although not significantly, higher for smokers of >14 cigarettes/day. Current alcohol drinkers were 147 (61.0%), former 
drinkers – 5 (2.1%), and non-drinkers – 89 (36.9%). The log(ΔFS) was weakly correlated only with the duration of alcohol consumption (p = 
0.028), but not with the mean number of drinks/day or the drink-years. 
Conclusions: Our study does not support the hypothesis that coffee or tea consumption is associated with the ALS progression rate, possible 
minor role for smoking and alcohol drinking was suggested.
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Abstract
Background: Cognitive impairment (CI) is frequent in Parkinson’s Disease (PD), having particular features. 
Material and methods: Sixty-five consecutive PD patients, (mean age 64.87 ± 7.69 y.o.; disease duration 50.21 ± 38.61 mo.; 48 women (43.2%), 
63 men (56.8%)) underwent MoCA and Beck tests. Cognitive status was graded as: (1) normal and (2) impaired cognition. 
Results: There were similar: ages (65.79 ± 7.13 vs 62.17 ± 12.21 y.o.), onset ages (61.44 ± 7.61 vs 57.00 ± 12.95 years), disease duration (49.63 ± 
36.78 vs 66.00 ± 26.48) months, levodopa (574.58 ± 129 vs 249.55) and agonists doses (5.19 ± 3.02 vs 1.05 ± 0.05) and Beck scores (8.13 ± 6.21 vs 
7.4 ± 3.85), in groups. CI was present in 59 (90.8%) patients; more frequent patients with cardiovascular risk factors (91.7% vs 80.0%, p > 0.05), 
symmetrical parkinsonism (41 pts (93.2%) vs 18 pts (85.7%), p > 0.05), and in first disease symptom bradykinesia patients (30 pts (93.8%) vs 23 
pts (85.2%), p > 0.05). Upper / Lower Asymmetry Indexes (0.60 ± 0.37 vs 2.4 ± 0.97, p > 0.05) were lower in CI patients, all lower type patients 
(15 pts (100%) vs 18 pts (85.6%), p > 0.05) having CI. MoCA scores correlated with UPDRS on (r = -0.320, p <0.022), and red flags number (r = 
-0.590, p < 0.006).
Conclusions: CI is more expectable in akinetic, symmetric and lower type parkinsonism, also in patients with cardiovascular risk factors, with 
probable PD, and a more motor impairment.
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